Jornay PM Interactions
There are 198 drugs known to interact with Jornay PM (methylphenidate), along with 14 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 20 are major, 167 are moderate, and 11 are minor.
- View all 198 medications that may interact with Jornay PM
- View Jornay PM alcohol/food interactions (4)
- View Jornay PM disease interactions (14)
Most frequently checked interactions
View interaction reports for Jornay PM (methylphenidate) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- albuterol
- amitriptyline
- Benadryl (diphenhydramine)
- bupropion
- buspirone
- cetirizine
- clonidine
- escitalopram
- famotidine
- fluoxetine
- gabapentin
- guanfacine
- hydroxyzine
- ibuprofen
- Lamictal (lamotrigine)
- lamotrigine
- melatonin
- metformin
- montelukast
- omeprazole
- ondansetron
- prednisone
- propranolol
- sertraline
- trazodone
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Zyrtec (cetirizine)
Jornay PM alcohol/food interactions
There are 4 alcohol/food interactions with Jornay PM (methylphenidate).
Jornay PM disease interactions
There are 14 disease interactions with Jornay PM (methylphenidate) which include:
- agitation
- cardiac disease
- glaucoma
- hypertension
- psychiatric disorders
- substance abuse
- tics
- hypertension
- seizures disorders
- liver disease
- renal dysfunction
- seizure disorders
- hematologic toxicity
- GI narrowing
More about Jornay PM (methylphenidate)
- Jornay PM consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CNS stimulants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.